News Orgenesis Inc.

Stocks

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 07:21:14 09/06/2026 pm IST			5-day change	1st Jan Change
0.4000 ^USD	-19.19%		-19.19%	+166.67%

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI

All News

Mentions Relevance

26/03	Orgenesis : Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)	PU
26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI
26/03	Okogen, Inc. acquired Global intellectual property portfolio and development assets for ranpirnase from Orgenesis Inc..	CI
14/03	Orgenesis Inc. Announces Board Appointments, Effective March 10, 2026	CI
14/03	Orgenesis Inc. Appoints Doug Karriker as Chief Financial Officer, Effective March 10, 2026	CI
26/25/26	Orgenesis Inc. Announces Resignation of Director Ashish Nanda, Effective August 21, 2025	CI
20/25/20	Orgenesis Inc. Announces Resignation of Victor Miller as Chief Financial Officer	CI
20/25/20	Orgenesis Inc. Announces Executive and Board Changes	CI
06/25/06	Orgenesis Inc. completed the acquisition of Certain assets of Neurocords LLC for $5.7 million.	CI
22/25/22	Orgenesis Inc. announced that it expects to receive $5 million in funding	CI
28/24/28	Orgenesis Inc. Announces Resignation of Jagannathan Bhalaji as A Director	CI
13/24/13	Orgenesis Provides Third Quarter 2024 Business Update	AQ
13/24/13	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
13/24/13	Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
02/24/02	Orgenesis Inc. Announces Board Appointments	CI
24/24/24	Orgenesis Inc. Announces Resignation of Mark Goodman as Director	CI
23/24/23	Orgenesis Inc.(NasdaqCM:ORGS) dropped from S&P TMI Index	CI
21/24/21	Orgenesis Commences Trading on OTCQX® Best Market	AQ
18/24/18	Orgenesis Inc.(OTCPK:ORGS) dropped from NASDAQ Composite Index	CI
23/24/23	Orgenesis Board Approves 1-for-10 Reverse Stock Split	MT
23/24/23	Orgenesis Announces Reverse Stock Split	AQ
29/24/29	Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia	AQ
29/24/29	Orgenesis Announces Positive Results from Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia	CI
15/24/15	Sector Update: Health Care Stocks Rise Late Afternoon	MT